new fda regulations for semaglutide approves first-ever oral GLP-1RA obesity and chronic weight management. Meet Wegovy (semaglutide) tablets. https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults Compounded "semaglutide" is not FDA-approved

Wegovy, the injectable version of semaglutide, is FDA-approved specifically for weight loss in people without diabetes

We actually naturally produce glutathione in our bodies, the liver specifically, and its one of the bodys most important and potent antioxidants

It is also worth reviewing whether your retatrutide dose has recently been increased, as gastrointestinal symptoms are more common during dose escalation

Of course, its early and Phase 3 trials will tell us more, but the numbers so far are unprecedented in obesity pharmacotherapy

What's next: Eli Lilly hasnt released a date for when it will seek approval by the Food and Drug Administration